BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
HISTORY: Chemische Werke LOWI founded in 1947
Spun off NIGU Chemie (1964)
NIGU Chemie acquired by SKW Trostberg AG (from 1987 to 1991)
Became a subsidiary of Degussa AG when SKW Trostberg AG merged with
Degussa-Huls AG
FACILITIES: State-of-the-art, GMP-conform production facilities for ultrapure guanidine
salts and a worldwide unique recycling plant for guanidine-containing
process waste
STOCK-FINANCIAL HISTORY: Privately held
SUBSIDIARIES/DIVISIONS: Nigu Bioselect is a business area of Nigu Chemie GmbH
SUBSIDIARY OF: Degussa AG
BUSINESS STRATEGY: Develop, produce and distribute fine and biochemicals for the
pharmaceutical, diagnostic and life science industry
PRODUCTS ON MARKET: Ultrapure guanidine hydrochloride
Ultrapure guanidine thiocyanate
Guanidine und derivatives
Recycling of guanidine containing process waste
Nippon Kayaku Co. Ltd.
Tokyo Fujimi Bldg., 11-2, Fujimi 1 chome, Chiyoda-ku
Tokyo 102-8172, Japan
Phone: +81 3-3237-5046; Fax: +81 3-3237-5081
Web: www.nipponkayaku.co.jp
E-mail: kouho@nipponkayaku.co.jp
KEY PERSONNEL: Koichiro Shimada; President
Masao Komaki; Director, Functional Chemicals Group
Akira Mandai; Director, Pharmaceuticals Group
Yoshiyuki Ikeda; General Manager, Safety Systems Division
Yoshiaki Fukushima; Director, Fine Chemicals Group
Hidetoshi Kitazawa; Director, Strategic Corporate Planning Group and
Director, R&D Group
Koichi Chiba; Director, Administration Group
Koichi Takase; President, Polatechno Co. Ltd.
EMPLOYEES: 1,933 employees
HISTORY: Established in June 1916
Began biotech research in 1980
Formed Kayaku Asta Medica, joint venture with Asta Medica AG, to develop
the anticancer drugs Cetrorelix and D21266 (6/95)
FACILITIES: Plants located in Tokyo, Takasaki, Kasima, Fukuyama, Asa, and Himeji;
plus four laboratories
Biotech production facility located at Takasaki plant
STOCK-FINANCIAL HISTORY: Listed on the Tokyo Stock Exchange
Net sales ¥134.205b (YE 05) compared to ¥128.016b (YE 04)
Net income ¥5.315b (YE 05) compared to ¥3.926b (YE 04)
Earnings per share ¥28.87/share (YE 05) compared to ¥21.22/share (YE 04)
SUBSIDIARIES/DIVISIONS: Organizaton:
Strategic Corporate Planning Group
Administration Group
Technical Operations Group
Research & Development Group: Research & Development Planning
Division, Intellectual Property Division, Functional Chemicals R&D
Laboratories, Pharmaceuticals Laboratories, Safety Systems Development
Laboratories, Agrochemicals Laboratories
Copyright ©2006 AHC Media ® 275